“Few, If Any, Doses of Spikevax or Comirnaty Available in United States, Despite FDA Approvals”
Stand up for the facts!
Our only agenda is to publish the truth so you can be an informed participant in democracy.
We need your help.
I would like to contribute
Vials of the Moderna COVID-19 vaccine are placed in a tray at a vaccination center in Tokyo on Jan. 22, 2022. (AP)
Spikevax and Comirnaty are brand names for existing COVID-19 vaccines, which are widely available
If Your Time is short
• Spikevax and Comirnaty are brand names for the Moderna and Pfizer COVID-19 vaccines, respectively. The drug formulation is the same for the branded and non-branded vaccines.
• The non-branded vaccines are widely available in the U.S., and Comirnaty also is available in the U.S.
Referring to COVID-19 vaccines by their brand names, an article headline misleads about their availability.
"Few, If Any, Doses of Spikevax or Comirnaty Available in United States, Despite FDA Approvals," reads the headline on a Feb. 2 article in The Epoch Times.
The article was shared on Facebook and flagged as part of Facebook’s efforts to combat false news and misinformation on its News Feed. (Read more about our partnership with Facebook.)
The article says, "U.S. drug regulators have now approved the COVID-19 vaccines made by Pfizer and Moderna, but the approved versions of the vaccines don’t appear to be available yet in the United States."
Spikevax and Comirnaty are brand names for the Moderna and Pfizer COVID-19 vaccines, respectively. The claim falsely implies that those vaccines, which have received approval from the U.S. Food and Drug Administration, are different from the non-branded vaccines that have been in use since December 2020 under the Emergency Use Authorization.
The drug formulation is the same for the branded and non-branded vaccines, and the two versions can be used interchangeably, according to the FDA and the drug companies.
Featured Fact-check
The non-branded vaccines are widely available in the U.S., and Comirnaty also is available in the U.S., according to a Pfizer spokesperson. Moderna did not respond to a request for comment.
Pfizer received FDA approval for its vaccine in August 2021, and Moderna received approval in January. After vaccines receive FDA approval, companies are allowed to market them under brand names, a Centers for Disease Control and Prevention spokesman told USA Today.
Our ruling
An article headline says, "Few, If Any, Doses of Spikevax or Comirnaty Available in United States, Despite FDA Approvals."
The claim falsely implies that Spikevax and Comirnaty are different from the non-branded COVID-19 vaccines that have been in use since December 2020. But the branded vaccines have the same formulation as the non-branded ones, which are widely available in the U.S.
Comirnaty also is available in the U.S.
We rate this claim False.
Our Sources
Email interview, Pfizer spokesperson, Feb. 3, 2022
The Epoch Times, "Few, If Any, Doses of Spikevax or Comirnaty Available in United States, Despite FDA Approvals," Feb. 2, 2022
USA Today, "Fact check: Pfizer's FDA-approved vaccine is available in US," Oct. 20, 2021
U.S. Food and Drug Administration, "Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older," Aug. 23, 2021
U.S. Food and Drug Administration, "Spikevax and Moderna COVID-19 Vaccine," accessed Feb. 4, 2022
Browse the Truth-O-Meter
More by Monique Curet
Spikevax and Comirnaty are brand names for existing COVID-19 vaccines, which are widely available
Support independent fact-checking.
Become a member!
In a world of wild talk and fake news, help us stand up for the facts.